Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females

References

• Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M J. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26
   PubMed Web of Science ®Google Scholar
• Oktay K H, Yih M. Preliminary experience with orthotopic and heterotopic transplantation of ovarian cortical strips. Semin Reprod Med 2002; 20: 63–74
   PubMed Web of Science ®Google Scholar
• Bleyer W A. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40: 355–367
   PubMed Web of Science ®Google Scholar
• Bines J, Oleske D M, Cobleigh M A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996; 14: 1718–1729
   PubMed Web of Science ®Google Scholar
• Tauchmanova L, Selleri C, Rosa G D, Pagano L, Orio F, Lombardi G, Rotoli B, Colao A. High prevalence of endocrine dysfunction in long-term survivors after allogenic bone transplantation for hematologic diseases. Cancer 2002; 95: 1076–1084
   PubMed Web of Science ®Google Scholar
• Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol 2005; 17: 299–308
   PubMed Web of Science ®Google Scholar
• Rose D P, Davis T E. Ovarian function in patients receiving adjuvant chemotherpy for breast cancer. Lancet 1997; 1: 1174–1176
   Google Scholar
• Chapman R M, Sutcliffe S B, Malpas J S. Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effect on sexual function. J Am Med Assoc 1979; 242: 1882–1884
   PubMed Web of Science ®Google Scholar
• Byrne J, Fears T R, Gail M H, Pee D, Connelly R R, Austin D F, Holmes G F, Holmes F F, Latourette H B, Meigs J W, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788–793
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003; 18: 90–95
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996; 11: 1620–1626
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Avivi I, Ritter M, Rowe J M. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Invest 1999; 6: 229–239
   PubMedGoogle Scholar
• Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 2000; 9: 401–405
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe J M. Fertility after treatment for Hodgkin's disease. Ann Oncol 2003; 13(Suppl 1)138–147
   Google Scholar
• Recchia F, Sica G, De Filippis S, Saggio G, Rosselli M, Rea S. Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anticancer Drugs 2002; 13: 417–424
   PubMed Web of Science ®Google Scholar
• Recchia F, Saggio G, Amiconi G, Di Blasio A, Cesta A, Candeloro G, Rea S. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 2006; 106: 514–523
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z. Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol 2003; 15: 359–370
   PubMed Web of Science ®Google Scholar
• Mardesic T, Snajderova M, Sramkova L, Keslova P, Sedlacek P, Stary J. Protocol combining GnRH agonist and GnRH antagonist for rapid suppression and prevention of gonadal damage during cytotoxic therapy. Eur J Gynaecol Oncol 2004; 1: 90–92
   Google Scholar
• Snajderova M. Drug combo preserves fertility during cancer treatment. Paper presented at: Endocrine Society 87th Annual Meeting, San Diego, CA, 4 – 7 Jun, 2005
   Google Scholar
• Oktay K, Sonmezer M, Oktem O. Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum non nocere. Human Reprod 2004; 19: 1681–1683
   PubMed Web of Science ®Google Scholar
• Ataya K, Moghissi K. Chemotherapy-induced premature ovarian failure: mechanisms and prevention. Steroids 1989; 5: 607–626
   Google Scholar
• Bokser L, Band S, Schally A V. Protective effects of D-Trp6 – luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats. Br J Cancer 1990; 61: 861–865
   PubMed Web of Science ®Google Scholar